Cargando…
Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
Background: Tigecycline was recently found to cause coagulation disorders, especially hypofibrinogenemia, which may interfere with the administration of antimicrobial therapy. This study aimed to investigate the incidence and clinical characteristics of and risk factors for tigecycline-associated hy...
Autores principales: | Leng, Bing, Shen, Chengwu, Gao, Tiantian, Zhao, Kai, Zhao, Xuemei, Guo, Yujin, Wu, Jiyong, Yang, Jing, Fang, Wei, Zhang, Jicheng, Zhang, Yahui, Sun, Chao, Duan, Lei, Huang, Jing, Qi, Yougang, Yan, Genquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592897/ https://www.ncbi.nlm.nih.gov/pubmed/36304151 http://dx.doi.org/10.3389/fphar.2022.943674 |
Ejemplares similares
-
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023) -
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021) -
A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia
por: Yılmaz Duran, Fulya, et al.
Publicado: (2018) -
Tigecycline-associated hypofibrinogenemia: A case report and review of the literature
por: Wu, Pei-Chun, et al.
Publicado: (2018) -
A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia
por: Wu, Xiaoqin, et al.
Publicado: (2017)